Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Pulmonx (LUNG) Cost of Revenue (2019 - 2025)

Pulmonx (LUNG) has disclosed Cost of Revenue for 7 consecutive years, with $5.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Cost of Revenue rose 1.66% to $5.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $24.5 million, a 50.95% increase, with the full-year FY2024 number at $21.8 million, up 21.56% from a year prior.
  • Cost of Revenue was $5.4 million for Q3 2025 at Pulmonx, down from $6.7 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $6.7 million in Q2 2025 to a low of $1.2 million in Q2 2024.
  • A 5-year average of $4.2 million and a median of $4.2 million in 2022 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: crashed 73.09% in 2024, then skyrocketed 454.58% in 2025.
  • Pulmonx's Cost of Revenue stood at $3.5 million in 2021, then rose by 22.68% to $4.2 million in 2022, then increased by 15.02% to $4.9 million in 2023, then grew by 26.59% to $6.2 million in 2024, then dropped by 11.74% to $5.4 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Cost of Revenue are $5.4 million (Q3 2025), $6.7 million (Q2 2025), and $6.2 million (Q1 2025).